Kaminvest Holding

Kamino Biotherapeutics is a biotechnology company developing a next-generation platform for circular RNA (oRNA) therapeutics and small molecules that modulate RNA biology. Circular RNA offers significant advantages over traditional linear mRNA, including enhanced stability, reduced immunogenicity, and prolonged protein expression within cells. The company's proprietary Kamino platform focuses on the efficient design, synthesis, and delivery of oRNA to treat a variety of conditions, including cancer and rare genetic disorders. Based in San Diego and with European roots through Kaminvest Holding, the company was founded by experienced biotech entrepreneurs and is currently in the pre-clinical stage of development.